Through immunohistochemistry (IHC) assays, we found that AK4 was highly expressed in human HER2-positive breast cancer tissues and investigated the link between the expression levels of AK4 and clinical features of patients who underwent HER2-positive breast cancer. Here, ERBB2 is linked to breast carcinoma.